In 2023, the FDA approved 55 new drugs and five gene therapies for rare diseases. Yet, there has been little progress in accelerating development timelines.
In 2023, the FDA approved 55 new drugs and five gene therapies for rare diseases. Yet, there has been little progress in accelerating development timelines.